Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
JoVE Journal
Immunology and Infection

A subscription to JoVE is required to view this content.
You will only be able to see the first 20 seconds.

JoVE Journal Immunology and Infection
Bygga upp en High-throughput Screening plattform att bedöma heterogenitet HER2 genen amplifiering i bröstcancer
 
Click here for the English version

Bygga upp en High-throughput Screening plattform att bedöma heterogenitet HER2 genen amplifiering i bröstcancer

Article doi: 10.3791/56686
December 5th, 2017 •
1, 1,2, 1,3, 1,2, 4, 5, 1, 4, 1, 1,6
1Division of Pathology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, 2School of Medicine, University of Milan, 3School of Biology, University of Pavia, 4Division of Breast Surgery, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, 5Division of Medical Oncology, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, 6Department of Biomedical, Surgical, and Dental Sciences, University of Milan

Summary
Automatic Translation
December 5th, 2017

Please note that all translations are automatically generated.

Click here for the English version.

Heterogen fördelning av HER2-positiva celler kan observeras i en delmängd av bröstcancer och genererar kliniska dilemman. Här introducerar vi en pålitlig och kostnadseffektiv protokoll för att definiera, kvantifiera och jämföra HER2 intra-tumör genetisk heterogenitet i en stor serie av heterogeneously bearbetade bröstcancer.

Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
simple hit counter